Sysmex Cor receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sysmex Corporation (6869)
The Sysmex share price today is 1,882.0, view TYO 6869 stock exchange data. Track the latest Sysmex share price with real-time updates on 6869 stock performance including market cap, day range, 52-week range and dividend yield. Access 6869 charts, earnings dates and analyst estimates to support your investment decisions.
1,882.0
-17.0(-0.90%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,862.5
1,909.5
52 wk Range
1,246.0
2,012.5
6869 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,862.51,909.5
52 wk Range
1,246.02,012.5
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.05%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.05%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6869 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
2,121.4
Upside
+12.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Healthcare Equipment & Supplies industry
Sysmex Cor receives Investment Bank Analyst Rating Update- Investing.com
Pro
Sysmex Cor receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Sysmex Cor receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sysmex Cor receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sysmex Cor receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Sysmex Cor receives Investment Bank Analyst Rating Update- Investing.com
Pro
Sysmex Cor receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Analyst Ratings
8 Buy
6 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2,121.4
(+12.72% Upside)
Sysmex Corporation Earnings Call Summary for Q2/2026
- Sysmex missed Q2 2025 forecasts with EPS of 23.2 (vs 24.06 expected) and revenue of ¥126.8B (vs ¥132.89B expected), causing shares to drop 5.65% after hours to ¥1610.
- The company revised its full-year sales forecast downward to ¥510B and operating income to ¥76B, while improving Q2 operating income ratio to 17.6%.
- Key challenges include yen depreciation, Chinese market conditions, geopolitical concerns in META region, and US supply chain issues with tariff impacts.
- Growth opportunities exist in emerging markets like India and Brazil, with planned European market entry for Hinotori medical robot and expansion of hemostasis business in Europe and US.
- Management expects recovery in Japanese and Chinese markets next year, while focusing on comprehensive laboratory solutions and establishing a training center for Hinotori.
Last Updated: 20-11-2025, 05:26 pm
Read Full TranscriptEarnings
Latest Release
07-08-2026
EPS / Forecast
14.17 / 10.12
Revenue / Forecast
130.67B / 117.36B
Compare 6869 to Peers and Sector
Metrics to compare | 6869 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6869PeersSector | |
|---|---|---|---|---|
P/E Ratio | 28.8x | 23.6x | −0.3x | |
PEG Ratio | −1.83 | 0.51 | 0.00 | |
Price/Book | 2.3x | 2.7x | 2.6x | |
Price / LTM Sales | 2.2x | 2.5x | 3.0x | |
Upside (Analyst Target) | 12.7% | 10.6% | 57.9% | |
Fair Value Upside | Unlock | 9.6% | 7.6% | Unlock |
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers hematology, a major test routinely included in blood tests; Flow Cytometry (FCM) analyzes cell properties by irradiating individual cells with a laser and measuring the intensity of light scattering and fluorescence; urinalysis test checks for the presence of glucose, proteins, and blood in urine; clinical chemistry; hemostasis; immunochemistry; cancer gene testing; and antimicrobial susceptibility testing. The company also provides Caresphere, an ICT solution, which integrates and analyzes real time various data managed through testing instruments and clinical testing information systems, and supports the efficient operation of clinical laboratories; and involved in the medical robotics business. It serves products and services to medical institutions, clinical laboratories, animal hospitals, and research institutes. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Sysmex (6869) Share Price Today?
The Sysmex share price today is 1,882.0.
What is the current Sysmex (6869) share price and day range?
As of 08-10-2026, the Sysmex share price is 1,882.0, with a previous close of 1,882.0. The share price has ranged from 1,862.5 to 1,909.5 today, while the 52-week range spans from 1,246.0 to 2,012.5.
What Is the Sysmex Market Cap?
As of today, Sysmex market cap is 1.14T.
Does Sysmex Pay Dividends? What's The Current Dividend Yield?
The Sysmex dividend yield is 2.05%.
What Is the Sysmex (6869) Share Price Target?
The average 12-month share price target for Sysmex is 2,121.4, with a high estimate of 3300 and a low estimate of 1500. 8 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +12.72% Upside potential.
What Is Sysmex's Earnings Per Share (TTM)?
The Sysmex EPS (TTM) is 63.8.
When Is the Next Sysmex Earnings Date?
Sysmex will release its next earnings report on 10-11-2026.
From a Technical Analysis Perspective, Is 6869 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Sysmex Trade On?
Sysmex is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Sysmex?
The stock symbol for Sysmex is "6869."
How Many Times Has Sysmex Stock Split?
Sysmex has split 4 times.
How Many Employees Does Sysmex Have?
Sysmex has 10861 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.